CN104127542B - A kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection - Google Patents

A kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection Download PDF

Info

Publication number
CN104127542B
CN104127542B CN201410377501.1A CN201410377501A CN104127542B CN 104127542 B CN104127542 B CN 104127542B CN 201410377501 A CN201410377501 A CN 201410377501A CN 104127542 B CN104127542 B CN 104127542B
Authority
CN
China
Prior art keywords
parts
radix
respiratory tract
tract infection
upper respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410377501.1A
Other languages
Chinese (zh)
Other versions
CN104127542A (en
Inventor
瞿德栋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Di Dedong
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410377501.1A priority Critical patent/CN104127542B/en
Publication of CN104127542A publication Critical patent/CN104127542A/en
Application granted granted Critical
Publication of CN104127542B publication Critical patent/CN104127542B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to a kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection, it comprises the medical materials such as Semen Armeniacae Amarum, Cortex Magnoliae Officinalis, Radix seu Herba Gei aleppici, Radix Scutellariae, Flos Lonicerae, lobus cardiacus Folium seu radix sidae mysorensis, Radix Puerariae, Radix Saposhnikoviae.The pharmaceutical composition for the treatment of children's repetitive upper respiratory tract infection of the present invention has the effects such as heat-clearing and toxic substances removing, dampness removing antiinflammatory, antiinflammatory removing heat from blood, lung qi dispersing antitussive, dispelling phlegm and relieving sore-throat; For the good effect of the symptom such as watery nasal discharge, nasal obstruction, cough, laryngopharynx swelling and pain that upper respiratory tract infection and anemopyretic cold cause, there is significant curative effects such as recovering soon, relapse rate is low, safety is high, have no side effect.

Description

A kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection.
Background technology
Respiratory tract infection is clinical common disease.Respiratory tract infection repeatedly refers to that respiratory tract infection number of times that infant occurs every year is more than 6 times, and twice interval time is more than 1 week.That treats the little repetitive upper respiratory tract infection of children's in the market mostly is compound Western medicine preparation, Western medicine is many containing chemical compositions such as antipyretic-antalgic class or central stimulant such as acetaminophen, chlorphenamine maleate and caffeine, to children's's gastrointestinal, hepatic and renal function to such an extent as to brain development all exists certain side effect, and it is many just for the various symptoms of flu, as remissions such as nasal obstruction, watery nasal discharge, coughs, to causing the virus of flu itself to there is no any therapeutical effect, cure the symptoms, not the disease.Mostly Chinese medicine is to disperse is main compound recipe or antipyretic and antidotal type medicine, often to cough-relieving, reduce phlegm, antiviral has effect, antipyretic response is not good enough again.Therefore, the medicine of new treatment children's repetitive upper respiratory tract infection is needed clinically.
Summary of the invention
The object of this invention is to provide a kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection.
In order to realize object of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection, it comprises the crude drug of following weight portion: Semen Armeniacae Amarum 1-10 part, Cortex Magnoliae Officinalis 1-5 part, Radix seu Herba Gei aleppici 5-20 part, Radix Scutellariae 1-10 part, Flos Lonicerae 5-15 part, lobus cardiacus Folium seu radix sidae mysorensis 5-20 part, Radix Puerariae 1-5 part, Radix Saposhnikoviae 1-10 part and Fructus Gardeniae 1-5 part.
Preferably, the pharmaceutical composition for the treatment of children's repetitive upper respiratory tract infection of the present invention comprises the crude drug of following weight portion: 5 parts, Semen Armeniacae Amarum, Cortex Magnoliae Officinalis 3 parts, Radix seu Herba Gei aleppici 10 parts, Radix Scutellariae 5 parts, Flos Lonicerae 8 parts, lobus cardiacus Folium seu radix sidae mysorensis 10 parts, Radix Puerariae 3 parts, Radix Saposhnikoviae 5 parts and Fructus Gardeniae 3 parts.
More preferably, the pharmaceutical composition for the treatment of children's repetitive upper respiratory tract infection of the present invention also comprises the crude drug of following weight portion: Semen Sojae Preparatum seven 1-10 part, Herba Apii graveolentis 10-20 part, Herba Solidaginis 5-25 part, Fructus Evodiae 5-25 part, Herba Kalanchoes Laciniatae 10-30 part, Cortex Rhamni Globosae Radicis 5-25 part, Radix et Rhizoma Smilacis Ripariae 10-30 part, Rhizoma Saururi (Herba Saururi) 10-30 part, Lignum Acronychiae 10-30 part and Ipomoea hungaiensis Lingelsh. Et Borza. 10-25 part.
Most preferably, the pharmaceutical composition for the treatment of children's repetitive upper respiratory tract infection of the present invention, it is characterized in that, it also comprises the crude drug of following weight portion: Semen Sojae Preparatum 78 parts, Herba Apii graveolentis 12 parts, Herba Solidaginis 10 parts, Fructus Evodiae 10 parts, Herba Kalanchoes Laciniatae 12 parts, Cortex Rhamni Globosae Radicis 10 parts, Radix et Rhizoma Smilacis Ripariae 12 parts, Rhizoma Saururi (Herba Saururi) 20 parts, Lignum Acronychiae 20 parts and Ipomoea hungaiensis Lingelsh. Et Borza. 20 parts.
Preferably, described pharmaceutical composition can be tablet, dispersible tablet, disintegrating tablet, rapidly dissolving tablet, enteric coatel tablets, ointment or decoction.
Generally acknowledged that " organic conception ", " determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs ", " compound recipe use ", " compound compatibility medication is as used military forces " are the traditional Chinese medical science the most effective most scientific several large advantages at present, wherein " compound compatibility medication is as used military forces " is the original theory of Chinese medicine of very science.The tight compatibility that in traditional Chinese medical science prescription, each medicine is all linked with one another as arrayed troops for battle is that it is better than the effective means of Western medicine formula.Tcm prescription theory is thought, each prescription, not only need to select the appropriate compatibility of suitable medicament according to etiology and pathogenesis, also should meet the basic structure of prescription simultaneously, the i.e. prescription compatibility theory of " monarch, minister, help, make ", the prescription compatibility of so-called " monarch, minister, help, make " is exactly that it is based upon the scientific matching on the comprehensive judgement basis of disease pathogenesis.In medical side by too many levels, Mutiple Targets Integrate adjustment biological mechanism, can to obtain than Western medicine more lastingly, the more therapeutic effect that has no side effect of green natural, and this curative effect be based upon the above-mentioned traditional Chinese medical science tradition original theory accurate instruction on, the present invention just have followed this principle.
For compositions of the present invention, according to the prescription compatibility theory of " monarch, minister, help, make ", lobus cardiacus Folium seu radix sidae mysorensis and Radix seu Herba Gei aleppici are monarch drug; Radix et Rhizoma Smilacis Ripariae, Flos Lonicerae, Herba Solidaginis, Semen Sojae Preparatum seven, Cortex Magnoliae Officinalis are ministerial drug; Rhizoma Saururi (Herba Saururi), Herba Kalanchoes Laciniatae, Semen Armeniacae Amarum, Radix Scutellariae, Cortex Rhamni Globosae Radicis, Radix Puerariae, Radix Saposhnikoviae, Fructus Gardeniae, Ipomoea hungaiensis Lingelsh. Et Borza. are adjuvant drug; Herba Apii graveolentis, Fructus Evodiae and Lignum Acronychiae are for making medicine.The efficient combination of said medicine, supports mutually, has the effects such as heat-clearing and toxic substances removing, dampness removing antiinflammatory, antiinflammatory removing heat from blood, lung qi dispersing antitussive, dispelling phlegm and relieving sore-throat, and achieves through clinical trial and useful be satisfied with technique effect.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
Take 5 grams, Semen Armeniacae Amarum, Cortex Magnoliae Officinalis 3 grams, Radix seu Herba Gei aleppici 10 grams, Radix Scutellariae 5 grams, Flos Lonicerae 8 grams, lobus cardiacus Folium seu radix sidae mysorensis 10 grams, Radix Puerariae 3 grams, Radix Saposhnikoviae 5 grams, Fructus Gardeniae 3 grams, Semen Sojae Preparatum 78 grams, Herba Apii graveolentis 12 grams, Herba Solidaginis 10 grams, Fructus Evodiae 10 grams, Herba Kalanchoes Laciniatae 12 grams, Cortex Rhamni Globosae Radicis 10 grams, Radix et Rhizoma Smilacis Ripariae 12 grams, Rhizoma Saururi (Herba Saururi) 20 grams, Lignum Acronychiae 20 grams and Ipomoea hungaiensis Lingelsh. Et Borza. 20 grams, add 3000 ml waters, heat 3 hours at 100 DEG C, filter, filtrate is cooled to room temperature, obtains decoction of the present invention.
Experimental example
Physical data
Be collected in the 50 children of going to a doctor to my institute year May in March, 2013 to 2014.All infants all meet Gynecology & Pediatrics Dept. medical diagnosis on disease criterion of therapeutical effect (1994) inside and outside the traditional Chinese medical science.Wherein man 25 example, female 25 example, children age 1-6 year between, average (4.3 ± 2.2) year.The infant that infant is all got rid of cardiomyopathy, draw kidney diaseases, disease in the blood system, immunodeficiency diseases and this treatment use immunosuppressant in first 1 month.
The decoction prepared in embodiment is used to treat, every day twice, oral 300 milliliters at every turn.Continuous treatment 15 days.And follow up a case by regular visits to 3 months.
Criterion of therapeutical effect
Recovery from illness: clinical symptoms disappears completely, occurs between follow-up period without upper respiratory tract infection.Effective: this upper respiratory tract infection symptoms disappears completely, between follow-up period, upper respiratory tract infection 1-2 time occurs, but each symptom is all slighter.Effective: this upper respiratory tract infection symptoms is alleviated to some extent, between follow-up period, upper respiratory tract infection 1-3 time occurs, comparatively compare symptom before treatment slight, the course of disease shortens.Invalid: this upper respiratory tract infection still has clinical symptoms through the treatment of 1 month, as cough and expectoration etc., and between follow-up period, still have upper respiratory tract infection to take place frequently.
Result
Through treatment, find in 50 routine infants, recovery from illness 42 example, effective 5 examples, effective 3 examples, total effective rate is 100%.
Model case
Health, female, 5 years old, National Day on October 2nd, 2013 gos for a ride with mother and plays, and opens wide automobile window, sleep soundly and catch cold in way, that night, with sending out hot body temperature 39.5 DEG C high, selects antibiotics, Western medicine of bringing down a fever, and moves back (all the time not lower than 38 DEG C) but soon bounces during high heat.Diagnosis: carve and examine: body temperature 39 DEG C, lethargy, whole body is lossless, and neck, body are scorching hot, Shou Zuleng, throat hypodynia, xerostomia thinks drink, and poor appetite, constipation with dry stool, yellow urine is few, and tongue is partially red, yellow and thin fur, floating and rapid pulse.The decoction prepared in embodiment is used to treat, every day twice, oral 300 milliliters at every turn.Continuous treatment 15 days.And follow up a case by regular visits to 3 months.Through treatment, clinical symptoms disappears completely, occurs between follow-up period without upper respiratory tract infection.
Xue so-and-so, man, 4 years old, infant generated heat, and cough, examines over three days, symptoms including cough, watery nasal discharge, gurgling with sputum, and two is just normal, indagation body temperature 38 DEG C, the micro-Huang of the red tongue of words and greasy, and swallow red, fingerprint purple, two pulmonary respiration sounds are thick.Accompany a little rale.The decoction prepared in embodiment is used to treat, every day twice, oral 300 milliliters at every turn.Continuous treatment 15 days.And follow up a case by regular visits to 3 months.Through treatment, clinical symptoms disappears completely, occurs between follow-up period without upper respiratory tract infection.
Liu, female, 2 years old, infant cough, rale, time have heating, once in treatments such as outer court's bronchopneumonia erythromycin, do not imitate.Its mother states diet difference, sleep disorder, and nocturnal cough is heavy, abundant expectoration tachypnea, and hope that its complexion owes China, spirit is also poor, the micro-fan of the wing of nose, and wheezing sound in the throat is sound, dry lip red tongue with yellowish and greasy fur, and fingerprint is livid purple, and two lungs have rale sound, and there is a little wet ring in the north.The decoction prepared in embodiment is used to treat, every day twice, oral 300 milliliters at every turn.Continuous treatment 15 days.And follow up a case by regular visits to 3 months.Through treatment, clinical symptoms disappears completely, occurs between follow-up period without upper respiratory tract infection.

Claims (1)

1. treat the pharmaceutical composition of children's's repetitive upper respiratory tract infection for one kind, it is characterized in that, it is made up of the crude drug of following weight portion: 5 parts, Semen Armeniacae Amarum, Cortex Magnoliae Officinalis 3 parts, Radix seu Herba Gei aleppici 10 parts, Radix Scutellariae 5 parts, Flos Lonicerae 8 parts, lobus cardiacus Folium seu radix sidae mysorensis 10 parts, Radix Puerariae 3 parts, Radix Saposhnikoviae 5 parts, Fructus Gardeniae 3 parts, Semen Sojae Preparatum 78 parts, Herba Apii graveolentis 12 parts, Herba Solidaginis 10 parts, Fructus Evodiae 10 parts, Herba Kalanchoes Laciniatae 12 parts, Cortex Rhamni Globosae Radicis 10 parts, Radix et Rhizoma Smilacis Ripariae 12 parts, Rhizoma Saururi (Herba Saururi) 20 parts, Lignum Acronychiae 20 parts and Ipomoea hungaiensis Lingelsh. Et Borza. 20 parts.
CN201410377501.1A 2014-08-01 2014-08-01 A kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection Expired - Fee Related CN104127542B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410377501.1A CN104127542B (en) 2014-08-01 2014-08-01 A kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410377501.1A CN104127542B (en) 2014-08-01 2014-08-01 A kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection

Publications (2)

Publication Number Publication Date
CN104127542A CN104127542A (en) 2014-11-05
CN104127542B true CN104127542B (en) 2016-01-20

Family

ID=51800564

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410377501.1A Expired - Fee Related CN104127542B (en) 2014-08-01 2014-08-01 A kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection

Country Status (1)

Country Link
CN (1) CN104127542B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106474376A (en) * 2016-12-14 2017-03-08 陈俊玲 A kind of Chinese medicine composition of pediatric treatment repetitive upper respiratory tract infection
CN107929502A (en) * 2017-12-08 2018-04-20 刘凡涛 A kind of Chinese medicine composition for treating children's upper respiratory tract infection and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1438038A (en) * 2003-02-19 2003-08-27 章炳炜 Chinese medicine formula for preventing common cold by fumigating air to act respiratory tract and using method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120085353A (en) * 2011-01-22 2012-08-01 장상훈 pathogenic avian influenza medicine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1438038A (en) * 2003-02-19 2003-08-27 章炳炜 Chinese medicine formula for preventing common cold by fumigating air to act respiratory tract and using method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
葛根芩连汤加味在儿科急症中的作用;王玉明等;《黑龙江中医药》;19951231(第2期);第24-25页,尤其是第24页右栏最后1段,第25页左栏第1-2段 *

Also Published As

Publication number Publication date
CN104127542A (en) 2014-11-05

Similar Documents

Publication Publication Date Title
CN101601830B (en) Chinese medicinal preparation for treating cold and preparation method thereof
CN101874880B (en) Method for preparing traditional Chinese medicine for treating pediatric wind-heat lung obstruction type pneumonia asthma
CN111388582A (en) Traditional Chinese medicine composition for treating novel coronavirus pneumonia and application of preparation thereof
CN103181970A (en) Traditional Chinese medicine composition for treating infectious coryza of chicken and preparation method for same
CN103977314A (en) Medicinal composition for treating respiratory diseases as well as preparation method and application of medicinal composition
CN105412858A (en) Syrup and preparation method thereof
CN101766787B (en) Enema liquid for treating hyperpyrexia and cough and asthma
CN104127542B (en) A kind of pharmaceutical composition for the treatment of children's's repetitive upper respiratory tract infection
CN100348235C (en) Chinese preparation for treating infantile diarrhea and its making method thereof
CN102139051B (en) Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia
CN104208473A (en) Traditional Chinese medicine composition for treating wind-heat type cough and asthma and use thereof
CN101322749B (en) Chinese medicine oral liquid for treating wind-heat cold and preparation thereof
CN102988948A (en) Medicament for treating infantile suppurative tonsillitis
CN105250843A (en) Medicament for treating cough due to wind-heat evil
CN103142733B (en) Chinese medicine composition for treating upper respiratory infection
CN101485730A (en) Medicament composition for treating children's exogenous fever and preparation method thereof
CN103721068B (en) A kind of medicament for the treatment of infantile anorexia
CN104096053A (en) Medicine composition for treating infantile pneumonia
CN102836203B (en) Traditional Chinese medicine composition for treating wind-heat type common cold as well as preparation method and application thereof
CN101601822A (en) A kind of medicine for the treatment of infantile cough and laryngeal stridor and preparation method thereof
CN104116960A (en) Traditional Chinese medicinal preparation for treating hand-foot-and-mouth disease
CN103961562A (en) Concentrated oral solution for treating recurrent oral ulcer by type of fire excess from yin deficiency
CN109833373A (en) A kind of enema for treating hand foot and mouth disease
CN105902943A (en) Medicine composition for treating wind heat cough of children
CN105920208A (en) Medicinal composition for treating infantile wind-heat type common cold

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CB03 Change of inventor or designer information

Inventor after: Di Dedong

Inventor before: Ji Dedong

COR Change of bibliographic data
CP01 Change in the name or title of a patent holder

Address after: 273100 Qufu Maternal and Child Health-Care Hospital, Jining Road, Qufu, Shandong 24, China

Patentee after: Di Dedong

Address before: 273100 Qufu Maternal and Child Health-Care Hospital, Jining Road, Qufu, Shandong 24, China

Patentee before: Ji Dedong

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160120

Termination date: 20160801

CF01 Termination of patent right due to non-payment of annual fee